Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide versus placebo added to CSII in adults with type 2 diabetes
2009-016384-11Phase 2Completed
- Sponsor
- CHU Caen Normandie
- Start
- Jan 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Exenatide + CSII insulin with Placebo + CSII insulin (2 arms). Primary endpoint: Change in HbA1c from baseline to 26 weeks. Started Jan 2010; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-016384-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016384-11.